Sign in

CIK 0001739174 · Non-accelerated filer<br>Smaller reporting company

Tessera Defense & Homeland Security Inc.

Sign in to watch
Ticker
HLSQ
Exchange
NYSE
Industry
Services-Prepackaged Software
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823364020
Phone
972 545610935
Business address
850 NEW BURTON ROAD, SUITE 201, DOVER, DE, 19904
Former names
BiomX Inc., Chardan Healthcare Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-07-11 Wolfson Marina Chief Financial Officer Grant or award · Common Stock Options - Right to Buy +950,000 950,000
2024-07-11 Solomon Jonathan Eitan Chief Executive Officer Grant or award · Common Stock Options - Right to Buy +3,805,000 3,805,000
2024-07-11 LEFF JONATHAN S Director Grant or award · Common Stock Options - Right to Buy +264,000 264,000
2024-07-11 GOODMAN JESSE Director Grant or award · Common Stock Options - Right to Buy +264,000 264,000
2024-07-11 Merril Gregory Louis Director Grant or award · Common Stock Options - Right to Buy +264,000 264,000
2024-07-11 Williams Eddie Director Grant or award · Common Stock Options - Right to Buy +176,000 176,000
2024-07-11 Oron Assaf Chief Business Officer Grant or award · Common Stock Options - Right to Buy +237,500 237,500
2024-07-11 Moses Alan Charles Director Grant or award · Common Stock Options - Right to Buy +176,000 176,000
2024-07-11 Flynn James E Director Grant or award · Stock Option (Right to Buy) +264,000 264,000
2024-07-09 Flynn James E Director Grant or award · Warrants +722,175 722,175
2024-07-09 Flynn James E Director Grant or award · Warrants +722,175 722,175
2024-07-09 Flynn James E Director Grant or award · Warrants +20,175,000 20,175,000
2024-07-09 Flynn James E Director Grant or award · Warrants +20,175,000 20,175,000
2024-05-15 OrbiMed Israel BioFund GP Limited Partnership 10% owner Option exercise +9,280,408 $0.24 $2.3M 13,797,997
2024-05-15 OrbiMed Israel BioFund GP Limited Partnership 10% owner Sale −24,344 $0.38 $9K 13,773,653
2024-05-15 OrbiMed Israel BioFund GP Limited Partnership 10% owner Option exercise · Warrants (Right to Buy) −9,280,408 0
2024-05-15 Cystic Fibrosis Foundation 10% owner Option exercise +4,778,265 $0.00 $5K 9,330,580
2024-05-15 Cystic Fibrosis Foundation 10% owner Option exercise · Warrant to purchase common stock −4,778,265 0
2024-03-15 Flynn James E Director Grant or award +3,055,049 3,055,049
2024-03-15 Flynn James E Director Grant or award +3,055,049 3,055,049

Page 4 of 12 · 240 trades